Company Comparison
Forty Seven vs AI Therapeutics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Forty Seven | AI Therapeutics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Menlo Park, California | San Diego |
| Founded | 2014 | — |
| Status | Active | Active |
| Last Funding Stage | Series C | Series A |
| Total Funding | $320M | $48M |
| Valuation | — | — |
What They Build
Forty Seven
Biotechnology company developing cancer immunotherapies targeting the CD47 pathway to enhance immune system recognition of cancer cells.
AI Therapeutics
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Key Investors
Forty Seven
AI Therapeutics
No investors listed.
Sector Overlap
Both Forty Seven and AI Therapeutics operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.